Showing 2,001 - 2,020 results of 6,439 for search '"Heart"', query time: 0.11s Refine Results
  1. 2001
  2. 2002
  3. 2003
  4. 2004
  5. 2005
  6. 2006
  7. 2007
  8. 2008
  9. 2009

    Intravenously Administered Human Umbilical Cord-Derived Mesenchymal Stem Cell (HucMSC) Improves Cardiac Performance following Infarction via Immune Modulation by Xiaoting Liang, Jing Liu, Mimi Li, Fang Lin, Rulin Zhuang, Qingshu Meng, Xiaoxue Ma, Yuanfeng Xin, Xin Gong, Zhiying He, Wei Han, Xiaohui Zhou, Zhongmin Liu

    Published 2023-01-01
    “…A small proportion of HucMSC is trafficked to the heart, preferentially in the infarcted region. HucMSC administration increased CD3+ T cell proportion in the periphery while decreased T cell proportion in both infarcted heart and mediastinal lymph nodes (med-LN) at 7-day post-MI, indicating a systematic and local T cell interchange mediated by HucMSC. …”
    Get full text
    Article
  10. 2010

    Human Neonatal Thymus Mesenchymal Stem Cells Promote Neovascularization and Cardiac Regeneration by Shuyun Wang, Shan Huang, Lianghui Gong, Zhize Yuan, Joshua Wong, Jeffrey Lee, Ming-Sing Si

    Published 2018-01-01
    “…Newborns with critical congenital heart disease are at significant risk of developing heart failure later in life. …”
    Get full text
    Article
  11. 2011
  12. 2012

    Accuracy of Apple Watch in Measuring 30-Second Resting Electrocardiography in Patients with Cardiac Diseases and Comorbidity: An Observational Cross-Sectional Study by Khushhal AA, Mohamed AA, Alsegame MM, Alsaedi AM

    Published 2025-01-01
    “…Alaa Abdulhafiz Khushhal,1 Ashraf Abdelaal Mohamed,1 Mohammad Matook Alsegame,2 Atif Mohammed Alsaedi2 1Department of Medical Rehabilitation Sciences, Faculty of Applied Medical Sciences, Umm Al-Qura University, Makkah, Saudi Arabia; 2Department of Nursing, Umm Al-Qura University Medical Center, Umm Al-Qura University, Makkah, Saudi ArabiaCorrespondence: Alaa Abdulhafiz Khushhal, Department of Medical Rehabilitation Sciences, Faculty of Applied Medical Sciences, Umm Al-Qura University, Makkah, Saudi Arabia, Tel +966536025182, Email aakhushhal@uqu.edu.saBackground: Electrocardiography (ECG) is a standard method for studying the heart rate and heart electricity. The Apple Watch has recently been used to measure heart electricity via 30 seconds of ECG monitoring, but its validity is not known.Methods: A cross-sectional study included a sample of 112 patients with chronic disorders, including cardiac patients with sinus rhythm, cardiac patients with irregular heart rhythm, and patients with diabetes, hypertension, and dyslipidemia; their cardiac activity was investigated using the Apple Watch and ECG.Results: The correlations were strong between the Apple Watch and the 12-lead ECG in the heart rate, PR intervals, QT intervals, QRS complex, and RR intervals in all patients’ subcategories (cardiac, hypertension, diabetic, and dyslipidemia patients).Conclusion: The Apple Watch is valid for carrying out ECG in measuring the heart rate, PR intervals, QT intervals, QRS complex, and RR intervals of patients with cardiac and chronic diseases at rest; this may help in initial diagnosis for patients with cardiac diseases or those who are at risk of developing cardiac disease in the future.Keywords: Apple Watch, electrocardiography, cardiac diseases, chronic diseases…”
    Get full text
    Article
  13. 2013

    A rare case of recurrent polychondritis with aortic valve involvement by N.V. Bortniak, O.A. Yepanchintseva, G.I. Kovtun, S.I. Dorofeieva, O.S. Chumak, G.M. Prus, O.J. Zharinov, B.M. Todurov

    Published 2018-11-01
    “…The most serious and prognostically unfavorable complication was damage to the cardiovascular system – a combined aortic heart disease with a predominance of stenosis with rapidly increasing circulatory decompensation. …”
    Get full text
    Article
  14. 2014
  15. 2015

    Multicenter study for CH-VAD as a fully magnetically levitated left ventricular assist device by Yifan Lu, Shuanglei Zhao, Jie Han, Qiang Lv, Xin Du, Zhengdong Hua, Keli Huang, Zhenwei Ge, Xiaoning Sun, Dan Zhu, Yongfeng Shao, Hongjia Zhang, Ming Gong

    Published 2025-02-01
    “…Patients had a mean age of 57.5 years, primarily classified as INTERMACS 2 or 3, with dilated and ischemic cardiomyopathy as the main causes of heart failure (HF). The study reported a 91.6% survival rate at both 6-month and 1-year follow-ups, aligning with international LVAD outcomes. …”
    Get full text
    Article
  16. 2016
  17. 2017
  18. 2018
  19. 2019
  20. 2020